Clinical trials
Active, not recruiting Phase 1 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 12 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| City of Hope Medical Center | 5 |
| M.D. Anderson Cancer Center | 5 |
| Dana-Farber Cancer Institute | 3 |
| Janssen Research & Development, LLC | 3 |
| Baylor College of Medicine | 2 |
| Jacqueline Garcia, MD | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Byondis B.V. | 1 |
| Cellectis S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 64 |
| Myelodysplastic Syndromes | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Leukemia, Biphenotypic, Acute | 6 |
| Leukemia, Myelomonocytic, Chronic | 6 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 5 |
| Hematologic Neoplasms | 5 |
| Recurrence | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Myeloproliferative Disorders | 4 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.